Y. Sibiril

675 total citations
25 papers, 535 citations indexed

About

Y. Sibiril is a scholar working on Plant Science, Immunology and Molecular Biology. According to data from OpenAlex, Y. Sibiril has authored 25 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Plant Science, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Y. Sibiril's work include Mycotoxins in Agriculture and Food (8 papers), Immunotoxicology and immune responses (3 papers) and RNA Interference and Gene Delivery (3 papers). Y. Sibiril is often cited by papers focused on Mycotoxins in Agriculture and Food (8 papers), Immunotoxicology and immune responses (3 papers) and RNA Interference and Gene Delivery (3 papers). Y. Sibiril collaborates with scholars based in France, Spain and Italy. Y. Sibiril's co-authors include D. Parent‐Massin, A.S. Ficheux, Nolwenn Hymery, Romain Froquet, Tristan Montier, Tony Le Gall, Augusto Pessina, Beatriz Albella, Laura Gribaldo and Rosette Van Den Heuvel and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Pharmaceutics and Toxicology.

In The Last Decade

Y. Sibiril

25 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Sibiril France 14 188 133 102 66 58 25 535
Silvia Casati Italy 21 166 0.9× 164 1.2× 196 1.9× 106 1.6× 275 4.7× 48 1.3k
Élida Álvarez Argentina 16 138 0.7× 354 2.7× 156 1.5× 93 1.4× 8 0.1× 45 696
Yuko Nukada Japan 13 84 0.4× 89 0.7× 135 1.3× 20 0.3× 55 0.9× 30 668
Magdalena Mizerska-Kowalska Poland 16 100 0.5× 250 1.9× 109 1.1× 56 0.8× 8 0.1× 31 543
Petr Mlejnek Czechia 18 75 0.4× 365 2.7× 63 0.6× 35 0.5× 23 0.4× 47 742
Marion Sweeney United Kingdom 13 462 2.5× 380 2.9× 23 0.2× 52 0.8× 26 0.4× 22 1.0k
Xiaojing Ma China 16 125 0.7× 516 3.9× 79 0.8× 60 0.9× 50 0.9× 38 895
Serena Galati Italy 13 61 0.3× 175 1.3× 38 0.4× 37 0.6× 66 1.1× 20 479
Xiaoli Liao United States 15 177 0.9× 488 3.7× 38 0.4× 27 0.4× 22 0.4× 37 785

Countries citing papers authored by Y. Sibiril

Since Specialization
Citations

This map shows the geographic impact of Y. Sibiril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Sibiril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Sibiril more than expected).

Fields of papers citing papers by Y. Sibiril

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Sibiril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Sibiril. The network helps show where Y. Sibiril may publish in the future.

Co-authorship network of co-authors of Y. Sibiril

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Sibiril. A scholar is included among the top collaborators of Y. Sibiril based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Sibiril. Y. Sibiril is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berchel, Mathieu, Tony Le Gall, Y. Sibiril, et al.. (2019). Antibacterial and transfection activities of nebulized formulations incorporating long n-alkyl chain silver N-heterocyclic carbene complexes. International Journal of Pharmaceutics. 567. 118500–118500. 18 indexed citations
2.
Resnier, Pauline, Y. Sibiril, Anne Clavreul, et al.. (2017). Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse. Pharmacological Research. 126. 54–65. 42 indexed citations
3.
Berchel, Mathieu, Y. Sibiril, Véronique Laurent, et al.. (2017). Antibacterial effect and DNA delivery using a combination of an arsonium-containing lipophosphoramide with an N-heterocyclic carbene-silver complex – Potential benefits for cystic fibrosis lung gene therapy. International Journal of Pharmaceutics. 536(1). 29–41. 11 indexed citations
4.
Resnier, Pauline, et al.. (2016). Challenges and Successes Using Nanomedicines for Aerosol Delivery to the Airways. Current Gene Therapy. 16(1). 34–46. 16 indexed citations
5.
Ficheux, A.S., Y. Sibiril, & D. Parent‐Massin. (2013). Effects of beauvericin, enniatin b and moniliformin on human dendritic cells and macrophages: An in vitro study. Toxicon. 71. 1–10. 27 indexed citations
6.
Ficheux, A.S., Y. Sibiril, & D. Parent‐Massin. (2012). Co-exposure of Fusarium mycotoxins: In vitro myelotoxicity assessment on human hematopoietic progenitors. Toxicon. 60(6). 1171–1179. 55 indexed citations
7.
Ficheux, A.S., Y. Sibiril, Raphaële Le Garrec, & D. Parent‐Massin. (2011). In vitro myelotoxicity assessment of the emerging mycotoxins Beauvericin, Enniatin b and Moniliformin on human hematopoietic progenitors. Toxicon. 59(1). 182–191. 16 indexed citations
8.
Pessina, Augusto, Arianna Bonomi, Loredana Cavicchini, et al.. (2010). Prevalidation of the Rat CFU-GM Assay for In Vitro Toxicology Applications. Alternatives to Laboratory Animals. 38(2). 105–117. 9 indexed citations
9.
Parent‐Massin, D., Nolwenn Hymery, & Y. Sibiril. (2009). Stem cells in myelotoxicity. Toxicology. 267(1-3). 112–117. 14 indexed citations
10.
Li, Wei, et al.. (2009). Synthesis and Antitumor Activity of Novel Dibutyltin Carboxylates of Aminoglucosyl Derivatives. Chemical Biology & Drug Design. 73(6). 682–686. 6 indexed citations
11.
Parent‐Massin, D. & Y. Sibiril. (2008). CFU‐MK Assay for Acute Thrombocytopenia. Current Protocols in Toxicology. 37(1). Unit 20.5–Unit 20.5. 2 indexed citations
12.
Hymery, Nolwenn, et al.. (2007). Human myelotoxicity of two phycotoxins, okadaic acid and domoic acid. Anin vitrostudy. Toxicological & Environmental Chemistry Reviews. 90(1). 141–152. 1 indexed citations
13.
Nasreddine, Lara, Nahla Hwalla, O. El Samad, et al.. (2006). Dietary exposure to lead, cadmium, mercury and radionuclides of an adult urban population in Lebanon: A total diet study approach. Food Additives & Contaminants. 23(6). 579–590. 49 indexed citations
14.
Hymery, Nolwenn, Y. Sibiril, & D. Parent‐Massin. (2006). Improvement of human dendritic cell culture for immunotoxicological investigations. Cell Biology and Toxicology. 22(4). 243–255. 19 indexed citations
15.
Hymery, Nolwenn, Y. Sibiril, & D. Parent‐Massin. (2006). In vitro effects of trichothecenes on human dendritic cells. Toxicology in Vitro. 20(6). 899–909. 52 indexed citations
16.
Benzinou, Abdesslam, et al.. (2006). Haematopoietic cell clusters quantification using image analysis. Biomedical Signal Processing and Control. 1(4). 282–288. 4 indexed citations
17.
Dréan, Gwenola Le, et al.. (2005). Myelotoxicity of trichothecenes and apoptosis: An in vitro study on human cord blood CD34+ hematopoietic progenitor. Toxicology in Vitro. 19(8). 1015–1024. 31 indexed citations
18.
Froquet, Romain, Y. Sibiril, & D. Parent‐Massin. (2001). Improvement of megakaryocytic progenitor culture for toxicological investigations. Toxicology in Vitro. 15(6). 691–699. 12 indexed citations
19.
Pessina, Augusto, Beatriz Albella, Juan A. Bueren, et al.. (2001). Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicology in Vitro. 15(6). 729–740. 89 indexed citations
20.
Froquet, Romain, Y. Sibiril, & D. Parent‐Massin. (2001). Trichothecene toxicity on human megakaryocyte progenitors (CFU-MK). Human & Experimental Toxicology. 20(2). 84–89. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026